GlassScriptPhysician profile
Jacqueline Papalios
NPI 1154867794
$7,429.87
in general payments reported to CMS, 2019-2025
29 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,571 · 2022: $1,058 · 2023: $2,164 · 2024: $1,462 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,201 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,200.64 |
| Travel and Lodging | $600.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,832.96 | 2021-2025 | Proclaim, Prodigy |
| Relievant Medsystems, INC. | $1,079.55 | 2023 | Intracept |
| Abbvie INC. | $995.07 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $937.88 | 2021-2025 | Xtampza, Belbuca |
| Pfizer INC. | $478.02 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $378.73 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Arbor Pharmaceuticals, INC. | $187.66 | 2021 | |
| Biodelivery Sciences International, INC. | $170.50 | 2021 | |
| Boston Scientific Corporation | $163.19 | 2024-2025 | Intracept, Varithena Administration Pack |
| Amgen INC. | $156.16 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $153.95 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $104.33 | 2024-2025 | |
| Tonix Medicines, INC. | $101.20 | 2025 | Tonmya |
| Spinal Simplicity, LLC | $90.47 | 2022-2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.69 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $76.87 | 2023-2024 | Mild Device Kit |
| Grt US Holding, INC. | $75.78 | 2021-2022 | |
| Curonix LLC | $68.89 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company LTD. | $68.89 | 2022 | |
| Averitas Pharma INC. | $44.70 | 2023-2025 | Qutenza |
| Bard Peripheral Vascular, INC. | $34.85 | 2024 | Venclose Maven Catheter |
| Allergan, INC. | $28.15 | 2021 | |
| Lundbeck LLC | $23.07 | 2024 | Vyepti |
| Scilex Pharmaceuticals INC. | $20.74 | 2024 | |
| Axsome Therapeutics, INC. | $20.41 | 2025 | Symbravo |
| Redhill Biopharma INC. | $14.50 | 2021 | |
| Biotronik Nro, INC. | $13.87 | 2025 | Prospera |
| Lilly USA, LLC | $12.60 | 2021 | |
| Supernus Pharmaceuticals, INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Papalios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.